ArticleMolecular therapy. Nucleic acids2022

Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer.

Timothy Samec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.